ArticleBMC urology2026
Prostatic morphometric parameters and ureteral access sheath placement failure during retrograde intrarenal surgery: a retrospective cohort study.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to evaluate the potential effect of benign prostatic hyperplasia-related prostatic morphometric parameters on ureteral access sheath (UAS) placement failure in male patients scheduled for retrograde intrarenal surgery (RIRS).
methodsBetween September 2019 and March 2025, 151 male patients scheduled for RIRS due to renal stones at a tertiary referral center were evaluated retrospectively after applying strict exclusion criteria to obtain a more homogeneous cohort. Patients with a preoperative ureteral stent, prior prostate surgery, alpha-blocker use, urethral or ureteral stricture, or unsuccessful passage of a 7.5 Fr semirigid ureteroscope were excluded. Patients were divided into UAS Successful (n = 93) and UAS Failure (n = 58) groups. Demographic characteristics, including body mass index (BMI), were obtained from the medical records. Hydronephrosis status and prostatic morphometric parameters, including intravesical prostatic protrusion (IPP), prostate volume (PV), prostatic urethral angle (PUA), and prostatic urethral length (PUL), were assessed on preoperative computed tomography by an experienced radiologist.
resultsIn comparative analyses, no statistically significant differences were found between the groups in terms of age, BMI, stone characteristics, or any of the assessed prostatic morphometric parameters (p > 0.05). Preoperative hydronephrosis was more frequent in the UAS Failure Group than in the UAS Successful Group (70.7% vs. 51.6%; p = 0.020). In univariable analysis, preoperative hydronephrosis was associated with higher odds of UAS placement failure (OR: 2.261; 95% CI: 1.127-4.537; p = 0.022). In the adjusted multivariable model, preoperative hydronephrosis remained independently associated with UAS placement failure (adjusted OR: 2.247; 95% CI: 1.103-4.581; p = 0.026), whereas none of the prostatic morphometric parameters showed an independent association. Length of hospital stay was significantly longer in the UAS Failure Group (p = 0.005).
conclusionProstatic morphometric parameters were not significantly associated with UAS placement failure, whereas preoperative hydronephrosis may be a potential factor associated with UAS placement failure. Given the selected nature of this cohort, larger multicenter studies including patients with a wider range of prostatic anatomy are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.